Related Experiment Video

Updated: May 22, 2026

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
07:13

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer

Published on: March 26, 2014

Molecular mechanisms of RET receptor-mediated oncogenesis in multiple endocrine neoplasia 2

Simona M Wagner1, ShuJun Zhu, Adrian C Nicolescu

  • 1Division of Cancer Biology and Genetics, Cancer Research Institute, Department of Pathology & Molecular Medicine, Queen's University, Kingston, ON, Canada.

Clinics (Sao Paulo, Brazil)
|May 16, 2012
PubMed

Insights

Multiple endocrine neoplasia type 2 (MEN2) is a hereditary cancer syndrome caused by RET gene mutations. Understanding these RET mutations improves MEN2 diagnosis and treatment strategies.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Multiple endocrine neoplasia type 2 (MEN2) is an inherited cancer syndrome.
  • It is characterized by tumors in thyroid and adrenal tissues.
  • Germline mutations in the REarranged during Transfection (RET) proto-oncogene cause unregulated activation, leading to MEN2.

Purpose of the Study:

  • To discuss the nature and effects of common recurrent RET mutations in MEN2.
  • To describe the molecular mechanisms underlying RET mutation-induced aberrant activation.
  • To explain the impact of these mutations on RET protein structure, function, localization, and signaling.

Main Methods:

  • Review of existing literature on RET mutations in MEN2.
  • Analysis of the molecular mechanisms of RET aberrant activation.
  • Description of the functional consequences of RET mutations on protein behavior.

Main Results:

  • Identified common recurrent mutations in the RET proto-oncogene as the cause of MEN2.
  • Detailed the molecular basis of RET aberrant activation due to specific mutations.
  • Described how these mutations affect RET protein structure, leading to altered signaling pathways.

Conclusions:

  • RET mutations are the primary drivers of MEN2, leading to unregulated proto-oncogene activation.
  • Understanding these genetic alterations is crucial for advancing the diagnosis and treatment of MEN2.
  • Further research into RET mutation mechanisms can inform targeted therapeutic strategies for this cancer syndrome.

More Related Videos

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

Reconstruct Human Retinoblastoma In Vitro06:52

Reconstruct Human Retinoblastoma In Vitro

Published on: October 11, 2022

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...